Correlation between serotonin uptake in human blood platelets with the 44-bp polymorphism and the 17-bp variable number of tandem repeat of the serotonin transporter

被引:66
作者
Kaiser, R
Müller-Oerlinghausen, B
Filler, D
Tremblay, PB
Berghöfer, A
Roots, I
Brockmöller, J
机构
[1] Univ Gottingen Klinikum, Klin Pharmakol Abt, D-37075 Gottingen, Germany
[2] Humboldt Univ, Klinikum Charite, Inst Clin Pharmacol, Berlin, Germany
[3] Free Univ Berlin, Klinikum Benjamin Franklin, Clin Psychopharmacol Res Grp, D-12200 Berlin, Germany
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 2002年 / 114卷 / 03期
关键词
serotonin transporter (5-HTT); VNTR; insertion/deletion polymorphism; serotonin uptake; pharmacogenetics;
D O I
10.1002/ajmg.10119
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Dysfunctions of the central serotonin (5-hydroxytryrptamine, 5-HT) system seem to be associated with psychiatric disorders such as schizophrenia or depression. Previous studies suggested that a 44-bp insertion/deletion polymorphism of the 5-HT transporter (5-HTT) promoter region might influence the transcriptional activity of the 5-HTT gene, and the insertion variant resulted in increased 5-HTT expression and 5-HT uptake. Moreover, a 17-bp variable number of tandem repeat (VNTR) polymorphism of the second intron may act as a transcriptional regulator with allele dependent differential enhancer-like properties. Since the 5-HTT of human platelets shares many properties with the transporter of neural tissue, platelets are widely used as a surrogate tissue source, possibly reflecting central 5-HT metabolism. Therefore, we investigated the impact of the 44-bp polymorphism and the 17-bp VNTR for 5-HT uptake in platelets of 50 male subjects. We found no significant effect of the 44-bp polymorphism and of the 17-bp VNTR on maximum rate (V-max) of 5-HT uptake. However, individuals homozygous for the 5-HTT intron 2 allele with 12 repeats (STin2.12) of the 17-bp VNTR appeared to have lower affinity of 5-HT uptake than individuals heterozygous for the STin2.10/STin2.9 allele. This was also observed for the combined analysis of both polymorphisms. In conclusion, we found no association between the different genotypes of the 44-bp polymorphism and the 17-bp VNTR and maximum rate of 5-HT uptake into platelets. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:323 / 328
页数:6
相关论文
共 33 条
[1]   A MODIFIED ASSAY-METHOD FOR DETERMINING SEROTONIN UPTAKE IN HUMAN-PLATELETS [J].
ARORA, RC ;
MELTZER, HY .
CLINICA CHIMICA ACTA, 1981, 112 (02) :225-233
[2]  
ARORA RC, 1989, PSYCHIAT RES, V32, P265
[3]   Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorder [J].
Battersby, S ;
Ogilvie, AD ;
Smith, CAD ;
Blackwood, DHR ;
Muir, WJ ;
Quinn, JP ;
Fink, G ;
Goodwin, GM ;
Harmar, AJ .
PSYCHIATRIC GENETICS, 1996, 6 (04) :177-181
[4]   Serotonin transporter gene polymorphism and schizophrenia: An association study [J].
BonnetBrilhault, F ;
Laurent, C ;
Thibaut, F ;
Campion, D ;
Chavand, O ;
Samolyk, D ;
Martinez, M ;
Petit, M ;
Mallet, J .
BIOLOGICAL PSYCHIATRY, 1997, 42 (07) :634-636
[5]   Platelets and psychiatry: Lessons learned from old and new studies [J].
Camacho, A ;
Dimsdale, JE .
PSYCHOSOMATIC MEDICINE, 2000, 62 (03) :326-336
[6]   The serotonin transporter is a potential susceptibility factor for bipolar affective disorder [J].
Collier, DA ;
Arranz, MJ ;
Sham, P ;
Battersby, S ;
Vallada, H ;
Gill, P ;
Aitchison, KJ ;
Sodhi, M ;
Li, T ;
Roberts, GW ;
Smith, B ;
Morton, J ;
Murray, RM ;
Smith, D ;
Kirov, G .
NEUROREPORT, 1996, 7 (10) :1675-1679
[7]  
Collier DA, 1996, MOL PSYCHIATR, V1, P453
[8]   A novel allelic variant of the human serotonin transporter gene regulatory polymorphism [J].
Delbrück, SJW ;
Wendel, B ;
Grunewald, I ;
Sander, T ;
Morris-Rosendahl, D ;
Crocq, MA ;
Berrettini, WH ;
Hoehe, MR .
CYTOGENETICS AND CELL GENETICS, 1997, 79 (3-4) :214-220
[9]   An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells [J].
Fiskerstrand, CE ;
Lovejoy, EA ;
Quinn, JP .
FEBS LETTERS, 1999, 458 (02) :171-174
[10]  
Greenberg BD, 1999, AM J MED GENET, V88, P83, DOI 10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.0.CO